Buy-rated reports

511 tickers rated Buy
NewestHighest Score Ranks all reports in this rating group by score, highest first.
McDonald's Corporation
MCD·Consumer Discretionary
A ★★★★Buy
Current$276.52
Target$303.60
Return+9.8%
Nov 7, 2026

McDonald's combines a dominant global franchise moat, recurring cash flow, and dependable dividends with a discounted historical earnings multiple, although soft U.S. traffic and substantial debt constrain growth and valuation upside.

Score
82
Cencora, Inc.
COR·Healthcare
A ★★★★Buy
Current$333.56
Target$371.93
Return+11.5%
Nov 7, 2026

Cencora combines a durable pharmaceutical distribution moat with expanding specialty healthcare earnings and attractive relative valuation, although acquisition-related leverage and reimbursement pressure may constrain future returns.

Score
82
Freshworks Inc.
FRSH·Technology
A ★★★★Buy
Current$12.70
Target$15.30
Return+20.5%
Nov 6, 2026

Freshworks offers profitable SaaS growth, rising enterprise adoption, and attractive cash-flow valuation, although modest customer expansion and intense competition could constrain long-term returns.

Score
82
Gartner, Inc.
IT·Technology
A ★★★★Buy
Current$198.07
Target$247.50
Return+25.0%
Nov 6, 2026

Gartner combines a durable enterprise research franchise and strong free cash flow with a discounted valuation, although slowing contract growth and AI-driven substitution threaten the sustainability of its historical premium.

Score
82
Sanofi
SNY·Healthcare
A ★★★★Buy
Current$44.96
Target$51.50
Return+14.5%
Nov 2, 2026

Sanofi offers strong immunology-driven growth, substantial free cash flow, and attractive forward valuation, but Dupixent concentration and eventual patent expiry create significant long-term earnings replacement risk.

Score
82
Granite Construction Incorporated
GVA·Industrials
A ★★★★Buy
Current$129.82
Target$139.86
Return+7.7%
Nov 2, 2026

Granite Construction offers growing infrastructure demand, record project commitments, and improving cash flow at a reasonable valuation, but materials-margin weakness and acquisition-related financing risks may limit shareholder returns.

Score
82
Sandisk Corporation
SNDK·Technology
A ★★★★Buy
Current$1,130.60
Target$1,680.00
Return+48.6%
Nov 2, 2026

Sandisk combines accelerating enterprise-storage demand, exceptional cash generation, and attractive earnings valuation, but its investment case remains vulnerable to NAND pricing normalization and semiconductor supply cycles.

Score
82
Covista Inc.
CVSA·Consumer Staples
A ★★★★Buy
Current$124.33
Target$145.60
Return+17.1%
Nov 1, 2026

Covista combines durable healthcare education demand, expanding online-program profitability, and strong cash generation at a reasonable valuation, although student-aid regulation and clinical capacity constraints could weaken growth.

Score
82
Jones Lang LaSalle Incorporated
JLL·Real Estate
A ★★★★Buy
Current$359.79
Target$405.00
Return+12.6%
Nov 1, 2026

JLL combines a global commercial real estate services franchise with improving transaction activity, operating leverage and buybacks, although cyclical property demand and competitive service pricing remain material risks.

Score
82
New Oriental Education & Technology Group Inc.
EDU·Consumer Staples
A ★★★★Buy
Current$48.68
Target$64.00
Return+31.5%
Oct 31, 2026

New Oriental offers a cash-rich Chinese education franchise with growing learning demand, improving shareholder returns, and an attractive valuation, although regulatory uncertainty and East Buy's lower-margin expansion could constrain profitability.

Score
82
Darling Ingredients Inc.
DAR·Consumer Staples
A ★★★★Buy
Current$55.73
Target$71.34
Return+28.0%
Oct 31, 2026

Darling Ingredients combines hard-to-replicate rendering infrastructure with improving renewable-fuel cash flows and debt reduction, offering attractive recovery upside despite volatile fuel margins and policy dependence.

Score
82
Universal Display Corporation
OLED·Technology
A ★★★★Buy
Current$83.92
Target$98.70
Return+17.6%
Oct 31, 2026

Universal Display offers a strong OLED patent and licensing franchise, significant cash generation, and historically discounted valuation, but weak materials margins and uncertain blue-emitter commercialization could delay an earnings recovery.

Score
82